baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BVT Knock-Out PGR/ DE000VM65563 /

21/06/2024 21:44:23	Chg.-0.12	Bid21:59:50	Ask21:59:50	Underlying	Strike price	Expiration date	Option type
7.18EUR	-1.64%	- Bid Size: -	- Ask Size: -	Progressive Corporat...	133.83 USD	31/12/2078	Call

GlobeNewswire 21/06 argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropat...

GlobeNewswire 21/06 Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 20...

GlobeNewswire 21/06 Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024

GlobeNewswire 21/06 XPPen Joins the RSA Schools Art Award 2024, Celebrating the Wonder of Art with the Young Generation

GlobeNewswire 21/06 Great Pacific Gold Announces New High-Grade Assays at Comet Discovery Including 4m at 22.3 g/t Gold

GlobeNewswire 21/06 Landmark Nature Medicine Study Reports Promising New Treatment Reduces Suffering in Sanfilippo syndr...

GlobeNewswire 21/06 Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and L...

GlobeNewswire 21/06 Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDi...

GlobeNewswire 19/06 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens

GlobeNewswire 18/06 Afamelanotide in fair-skinned Parkinson’s patients

GlobeNewswire 14/06 Progressive Reports May 2024 Results

GlobeNewswire 13/06 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...

GlobeNewswire 12/06 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...

GlobeNewswire 12/06 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...

GlobeNewswire 11/06 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...

GlobeNewswire 11/06 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...

GlobeNewswire 11/06 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...

GlobeNewswire 10/06 LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...

GlobeNewswire 10/06 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...

TeleTrader 09/06 EP updated results, EPP with 189 seats

TeleTrader 09/06 EPP's Weber claims party victory in EP election

GlobeNewswire 07/06 TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire 07/06 Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsenin...

GlobeNewswire 06/06 Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple...

GlobeNewswire 06/06 4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...

BVT Knock-Out PGR/ DE000VM65563 /

If you wish to receive reply to your feedback, please provide your email address.